
"Rate hikes will have a positive income on the margin profile of BFSI companies depending on asset and liability mix. Similarly, select Pharma companies have a healthy growth profile, with strong balance sheets and cash generation profile."
from Moneycontrol Market Outlook https://www.moneycontrol.com/news/market-outlook/daily-voice-|-pharma-autobfsi-look-attractivemedium-term-perspective-especially-after-correction-says-darshan-engineerkarma-capital_16445341.html
No comments:
Post a Comment